Overview
Apokyn is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2004 to treat intermittent “off” episodes in people with advanced Parkinson’s disease. Apokyn is also referred to by its…

Overview
Azilect is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2006 to treat motor symptoms in people with Parkinson’s disease. Azilect may be prescribed as a monotherapy to people…

Overview
Comtan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjunct (add-on) drug to levodopa/carbidopa if the latter drugs begin to lose effectiveness in treating motor symptoms…

Overview
Crexont is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, post-encephalitic parkinsonism (Parkinson-like symptoms following brain inflammation), and parkinsonism…

Overview
Dhivy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, as well as post-encephalitic parkinsonism and symptomatic parkinsonism caused by carbon monoxide or…

Overview
Duopa is a prescription drug approved by the Food and Drug Administration (FDA) in 2015 to treat fluctuating motor symptoms in those with advanced Parkinson’s Disease. Duopa may be prescribed if your condition…

Overview
Eldepryl is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1989 to treat motor symptoms in people with Parkinson’s disease. Eldepryl may be prescribed as a monotherapy to people…

Overview
Exelon is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2000 to treat mild to moderate dementia in people with Parkinson’s disease. Exelon may also be prescribed to treat…

Overview
Gocovri is a prescription drug approved by the U.S.Food and Drug Administration (FDA) to treat dyskinesia (movement disorder) in people with Parkinson’s disease who are also receiving levodopa-based therapy…

Overview
Inbrija is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat “off” episodes in people with Parkinson’s disease (PD) who are taking oral levodopa/carbidopa
Inbrija is an…